Pages that link to "Q37301013"
Jump to navigation
Jump to search
The following pages link to Functional effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in parkinsonian rhesus monkeys (Q37301013):
Displaying 50 items.
- A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects (Q26746033) (← links)
- Gene-based therapy of Parkinson's Disease: Translation from animal model to human clinical trial employing convection enhanced delivery (Q26851517) (← links)
- Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease (Q27309140) (← links)
- Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson's Disease (Q27320553) (← links)
- A monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeys (Q28728201) (← links)
- Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound (Q30277809) (← links)
- Autologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques (Q30530883) (← links)
- Neuroregeneration in neurodegenerative disorders (Q31020342) (← links)
- Neurotrophin gene therapy for sustained neural preservation after deafness (Q31110179) (← links)
- Current Experimental Studies of Gene Therapy in Parkinson's Disease (Q33627771) (← links)
- Convection-enhanced delivery of AAV2-PrPshRNA in prion-infected mice (Q33670676) (← links)
- AAV2 mediated retrograde transduction of corticospinal motor neurons reveals initial and selective apical dendrite degeneration in ALS. (Q33726831) (← links)
- Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys (Q33819946) (← links)
- Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS (Q33894621) (← links)
- Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF. (Q34039452) (← links)
- Guided delivery of adeno-associated viral vectors into the primate brain (Q34061373) (← links)
- Real-time MR imaging with Gadoteridol predicts distribution of transgenes after convection-enhanced delivery of AAV2 vectors (Q34080874) (← links)
- Evaluation of an AAV2-Based Rapamycin-Regulated Glial Cell Line-Derived Neurotrophic Factor (GDNF) Expression Vector System (Q34087812) (← links)
- Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain (Q34892014) (← links)
- Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease (Q35086686) (← links)
- Stem cell technology for neurodegenerative diseases. (Q35224202) (← links)
- Neurorestoration (Q35631869) (← links)
- Eicosanoid receptor subtype-mediated opposing regulation of TLR-stimulated expression of astrocyte glial-derived neurotrophic factor (Q36055556) (← links)
- Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor (Q36128982) (← links)
- Activin A Inhibits MPTP and LPS-Induced Increases in Inflammatory Cell Populations and Loss of Dopamine Neurons in the Mouse Midbrain In Vivo. (Q36259630) (← links)
- Anti-oncogenic perspectives of spices/herbs: A comprehensive review (Q36785236) (← links)
- Direct and retrograde transduction of nigral neurons with AAV6, 8, and 9 and intraneuronal persistence of viral particles (Q36945745) (← links)
- Transcription factor Six2 mediates the protection of GDNF on 6-OHDA lesioned dopaminergic neurons by regulating Smurf1 expression (Q37030300) (← links)
- Comparison of fetal mesencephalic grafts, AAV-delivered GDNF, and both combined in an MPTP-induced nonhuman primate Parkinson's model (Q37393795) (← links)
- Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys (Q37399627) (← links)
- Treatment strategies for Parkinson's disease (Q37681312) (← links)
- Progress and prospects: Immunobiology of gene therapy for neurodegenerative disease: prospects and risks (Q37690581) (← links)
- Glial Cell Line-Derived Neurotrophic Factor Gene Delivery in Parkinson's Disease: A Delicate Balance between Neuroprotection, Trophic Effects, and Unwanted Compensatory Mechanisms. (Q37742852) (← links)
- Neurotrophic factor therapy for Parkinson’s disease (Q37796025) (← links)
- Gene therapy for Parkinson’s disease: where are we now and where are we going? (Q37810994) (← links)
- Trophic factor gene therapy for Parkinson's disease (Q38079792) (← links)
- Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications (Q38166648) (← links)
- Advances in non-dopaminergic treatments for Parkinson's disease (Q38218083) (← links)
- Viral vector delivery of neurotrophic factors for Parkinson's disease therapy (Q38495722) (← links)
- Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases (Q38808008) (← links)
- Intrastriatal gene delivery of GDNF persistently attenuates methamphetamine self-administration and relapse in mice (Q39190198) (← links)
- Non-human primate models of PD to test novel therapies (Q39229450) (← links)
- Adeno-associated virus type 2 vector-mediated glial cell line-derived neurotrophic factor gene transfer induces neuroprotection and neuroregeneration in a ubiquitin-proteasome system impairment animal model of Parkinson's disease. (Q39342788) (← links)
- Cell replacement therapy is the remedial solution for treating Parkinson's disease (Q39446547) (← links)
- An engineered zinc finger protein activator of the endogenous glial cell line-derived neurotrophic factor gene provides functional neuroprotection in a rat model of Parkinson's disease. (Q39621442) (← links)
- Anterograde axonal transport of AAV2-GDNF in rat basal ganglia (Q39628466) (← links)
- Overexpression of Shati/Nat8l, an N-acetyltransferase, in the nucleus accumbens attenuates the response to methamphetamine via activation of group II mGluRs in mice (Q42235808) (← links)
- Is GDNF beneficial in Parkinson disease? (Q43709637) (← links)
- Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments (Q45873810) (← links)
- Ganglioside Metabolism and Parkinson's Disease (Q49829715) (← links)